Posted in | News | Plastics and Polymers | Automotive Materials

Sumitomo Chemical and Toyo Ink Manufacturing to Establish Polypropylene Compound Company in China

Apr 6 2005

Related Stories

Sumitomo Chemical has announced its plan to establish in May a new company in China to manufacture and sell polypropylene compounds for automotive applications.

To be headquartered in Zhuhai, Guangdong Province, the new company provisionally called Sumika Polymer Compounds (Zhunhai) will be owned 55% by Sumitomo Chemical and 45% by Toyo Ink Manufacturing.

Demand for polypropylene compounds is rapidly rising from Japanese automakers expanding their operations in southern China.

The new company will have an initial production capacity of 10,000 tons per year, and will eventually double the capacity to 20,000 tons.

Manufacturing operations are slated to begin in mid-2006.

http://www.sumitomo-chem.co.jp/english/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
(Logout)
Your comment type
Submit

Sponsored Content

Editorial Highlights

The Current State of the Global Semiconductor Market

The Current State of the Global Semiconductor Market

The global semiconductor market has entered an exciting period. Demand for chip technology is both driving the industry as well as hindering it, with current chip shortages predicted to last for some time. Current trends will likely shape the future of the industry, which is set to continue to show

How are Graphene Batteries Made?

How are Graphene Batteries Made?

The primary distinction between graphene-based batteries and solid-state batteries lies in the composition of either electrode. Although the cathode is commonly changed, carbon allotropes can also be employed in fabricating anodes.

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback